Traditional imaging technologies such as organic fluorescent dyes and quantum dots have significant defects: Photobleaching leads to signal loss as seen when A647 dye converts to blue light after exposure while autofluorescence from biological tissues creates background noise that disrupts signal clarity because tissues exhibit natural fluorescence under visible light stimulation and visible light fails to effectively penetrate biological tissues due to heavy scattering and absorption. Upconverting nanoparticles (UCNPs) function by doping lanthanide elements like Yb³⁺, Er³⁺, and Tm³⁺ to transform near-infrared light at 980nm into visible or ultraviolet light through the anti-Stokes effect which surpasses current limitations.
High tissue penetration depth: NIR excitation demonstrates superior penetration through biological tissues which allows imaging depths of several centimeters making it ideal for deep tumor visualization like targeted in situ liver cancer models.
Low background noise: NIR excitation can avoid biological autofluorescence interference (autofluorescence is mainly located at 400-600nm) and significantly improve imaging sensitivity (detection limit can reach single cell level).
Anti-photobleaching: The inorganic crystal structure of UCNPs (such as NaYF4 matrix) makes its luminescence stability better than that of organic dyes (although quantum dots are resistant to photobleaching, they have fluorescence flickering).
Multimodal compatibility: It can be combined with MRI, CT and other technologies (such as Gd³⁺-doped UCNPs to achieve MRI/upconverting luminescence dual-modal imaging), providing multidimensional information (synergistic analysis of anatomical structure and molecular function).
Upconverting Nanoparticles Products List
Optical and Physical Properties of UCNPs
The luminescence of UCNPs originates from the step-by-step energy level transition of lanthanide ions. For example, after Yb³⁺ absorbs NIR photons (980nm), it excites Er³⁺ (emitting green light, 550nm) or Tm³⁺ (emitting blue light, 450nm) through energy transfer, and finally emits visible light through the anti-Stokes effect. By adjusting the ratio of doped ions (such as Yb³⁺/Er³⁺ or Yb³⁺/Tm³⁺), the emission spectrum can be customized (covering the ultraviolet to near-infrared band). For example, Ho³⁺ doping can achieve multicolor imaging. The energy transfer efficiency is affected by the crystal field symmetry. The core-shell structure (such as NaYF4@NaYF4) can increase the quantum efficiency to more than 5% by reducing surface defects.
Unmodified UCNPs are prone to aggregation due to hydrophobicity, and surface treatment is required to improve biocompatibility:
Hydrophilic coating: Polyethylene glycol (PEG) modification can reduce immune clearance (extend blood circulation half-life to more than 6 hours) and enhance passive tumor targeting (EPR effect).
Functional modification: Silica coating (increase water solubility and reduce toxicity) or antibody coupling (such as anti-HER2 antibody to achieve breast cancer targeting) can improve specificity; folate receptor targeted modification achieves rapid tumor aggregation in lymphoma models (development 2 hours after injection).
Core-shell structure optimization: NaYF4@NaYF4 core-shell design can increase the luminescence intensity by 10 times, while the Fe3O4@NaYF4 composite structure integrates magnetism (for MRI imaging) and upconverting luminescence to achieve integrated diagnosis and treatment.
Energy transfer synergy: UCNPs combined with quantum dots (such as through the FRET mechanism) can achieve multi-color emission with near-infrared excitation, avoiding the interference of spontaneous fluorescence of biological tissues.
In-depth Analysis of UCNPs Core Application Areas
Bio-imaging: From single-mode to multi-modal precision imaging
Deep in vivo imaging: UCNPs use near-infrared (NIR, such as 980 nm or optimized 915 nm) excitation light to penetrate biological tissues to a depth of several centimeters, which is significantly better than traditional visible light-excited fluorescent probes (penetration is only at the millimeter level). For example, NaYbF4:Tm@NaGdF4 core-shell structure UCNPs achieve high-resolution imaging of the liver and spleen in living mice, and are targeted after modification with citric acid ligands. It is worth noting that UCNPs excited at 800 nm can reduce thermal damage caused by water molecule absorption, and the penetration depth is increased to 25 mm, providing a new solution for deep tumor imaging.
Multimodal imaging synergistic technology: Through rare earth ion doping, UCNPs can be used as MRI contrast agents (relaxation rate up to 5.60 s⁻¹·mM⁻¹) and fluorescent probes at the same time, such as NaGdF4:Yb/Er/Tm system combined with SPECT/CT technology to achieve simultaneous visualization of anatomical structure and metabolic function. In addition, ¹⁸F-labeled UCNPs (such as cit-NPs) can integrate PET/MRI/UCL trimodal imaging, with both sensitivity and spatial resolution, suitable for multi-level detection from cells to living bodies.
Nanoscale temperature measurement: from macro to super-resolution thermal imaging
The luminescence intensity ratio (FIR) of UCNPs is highly sensitive to temperature, especially using the ²H₁₁/₂ and ⁴S₃/₂ thermal coupling energy levels of Er³⁺ (energy level difference ~800 cm⁻¹), which can monitor local temperature changes in cells at the nanoscale (<100 nm). For example, the CaF2:Yb/Er@NaGdF4 core-shell structure uses super-resolution microscopy to achieve accurate temperature measurement of tumor metabolic hotspots (such as mitochondria) with a sensitivity of 0.5°C, providing tools for thermal management of electronic devices or research on abnormal cancer metabolism. In addition, Tm³⁺-doped UCNPs (such as Y₂O₃:Yb/Tm) have a smaller energy level difference (~315 cm⁻¹) and show higher temperature measurement accuracy in the low temperature range (25-45°C), which is suitable for real-time temperature feedback in photothermal therapy.
Cancer Theranostics: From Basic Research to Clinical Transformation
Integration of Diagnosis and Treatment Functions: Single-particle UCNPs can achieve imaging and treatment at the same time. For example, the NaYF4:Yb/Er@NaGdF4 core-shell structure is loaded with photosensitizer Bengal red (RBHA) and platinum drug (Pt(IV)). Under 980 nm excitation, the ultraviolet light emitted by UCNPs activates RBHA to produce reactive oxygen species (ROS), while releasing Pt(IV) for chemotherapy, and the tumor inhibition rate in mice is increased to 82%.
Targeted and precise delivery: UCNPs modified with antibodies (such as anti-ErbB2) or functionalized with aptamers can specifically recognize tumor markers. For example, UCNPs modified with folic acid are endocytosed by folate receptors, and the targeting efficiency in ovarian cancer models is 6 times higher than that of the unmodified group. The DNA aptamer-guided UCNPs-QDs heterostructure can recognize nucleolin overexpressed on the tumor cell membrane, realizing dual-modality imaging and controlled drug release.
Photodynamic/photothermal synergistic therapy: Optimize photoconversion efficiency through core-shell engineering, such as NaYF4:Yb/Er@Au structure converts NIR light into localized surface plasmon resonance (LSPR), generates high temperature (>50°C) to ablate tumors, and the gold shell layer enhances photothermal stability.
Innovative Expansion of Other Medical Applications
Ultra-high sensitivity immunoassay: UCNPs are used as probes to detect cancer markers (such as CEA), and the signal-to-noise ratio (SNR) is 10 times higher than ELISA. The UCNPs-GNPs system designed by the FRET mechanism can detect human IgG as low as 0.1 nM, with a sensitivity spanning 3 orders of magnitude.
Optogenetic neuromodulation: Tm³⁺-doped UCNPs emit 470 nm blue light, which can accurately activate light-sensitive channel proteins (such as ChR2) and regulate neuronal action potentials, providing a new way to intervene in neurological diseases such as Parkinson's disease.
UCNPs Technical Challenges and Breakthrough Solutions
Toxicity Issues: From Biocompatibility to Long-term Safety
Although PEGylation or silica coating (such as SiO₂@UCNPs) can reduce cytotoxicity to IC₅₀ > 200 μg/mL, long-term biodistribution still needs attention. For example, 10% of PAA-coated NaYF4:Yb/Er is still retained in the liver after 115 days in mice, and renal clearance needs to be accelerated by size control (<10 nm) or degradable shell (such as CaF₂).
Synthesis Process Optimization: From Trial and Error to Computational Driven
The traditional thermal decomposition method is time-consuming and has a low yield (<30%) for the synthesis of core-shell structures. High-throughput microfluidics technology combined with machine learning models (such as DFT calculations) can increase the synthesis efficiency of NaYF4@NaGdF4 to 90%, and accurately predict the effect of shell thickness on luminescence efficiency.
Tissue penetration limit: Breakthrough from NIR-I to NIR-II region
Developing UCNPs (such as Er³⁺-doped NaYF4) emitting in the NIR-II region (1500-1700 nm) can reduce tissue scattering and absorption, increase penetration depth to 5 cm, and reduce thermal damage by 60%. Combined with photoacoustic imaging (PAI) technology, dual-mode high-resolution imaging of tumor blood vessels and solid tumors can be achieved.
Related Product & Service
Upconverting Nanoparticles
